IntroductIon
Yellow fever is an important hemorrhagic arboviral infection reported from many parts of Africa and central South America. It is categorised under category 'C' of potential bioterrorism agent under NIAID list 1 . It is also included under the export control list of Australia Group 2 . This is a zoonotic disease, transmitted by both sylvatic and urban cycle. In sylvatic cycle, the transmission occurs between Aedes mosquitoes and monkey in the forest, as monkeys are the main reservoirs. In urban areas, Ae. aegypti mosquitoes transmit the virus to humans 3, 4 . An estimated 200,000 cases of yellow fever occurs each year worldwide, with the case-fatality rate of ~15 per cent 5 . From 1700 to early 1900, YF outbreaks were recorded, however close study of this disease was done during Spanish-American War and construction of the Panama Canal in late 19 th century 6 . YFV is the prototype virus of genus Flavivirus in family Flaviviridae. It is a small, enveloped virus that contains a single positive strand RNA as its genome, which is ~11 kb in size. It encodes a single ORF that consists of three structural and seven non structural proteins in the following order: 5' -C-prM(M)-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5- 3' 7 .
Most of the YF infections are asymptomatic, but in some cases, there is fever, muscle pain, headache and vomiting are reported. However severe illness involves jaundice, abdominal pain and haemorrhagic manifestations, which may lead to death after 10-14 days of the onset of illness 8 . There is no specific antiviral therapy against YFV except the YF 17D vaccine. This is a live attenuated formulation, which is safe and affordable and has been in practice since 1940s. During the initial passages, this strain was neurotropic, which lost its pathogenicity at 114 th passage for both mice and monkeys 6 . The vaccine provides immunity within a week to 95 per cent of vaccinees. Long lasting protection (>30 yrs) against YFV can be obtained through a single dose of this vaccine with rare side effects 5 . According to CDC, YF vaccination is not recommended in areas, involving low potential for YFV. It should be considered for travellers that are travelling to YFV endemic areas, or when travelling to areas that are heavily exposed with mosquitoes 9 . Government of India recommends the vaccination for Indians travelling to the endemic countries of Africa and South America. The vaccine virus replicate slowly in humans, leading to a risk of transmission from vaccinees to mosquitoes, which can further replicate within the mosquitoes and can be potentially transmitted to naïve individuals. Therefore, there is a need to evaluate the replication and transmission efficiency of the Indian Ae. aegypti mosquitoes to transmit YF 17D vaccine. In 
AbStrAct
Yellow fever virus (YFV) is the causative agent of yellow fever. It is one of the most important hemorrhagic arboviral infection of global public health significance. It is categorised under category 'C' of potential bioterrorism agent. Effect of geographical variation on vector competence in Ae. aegypti has been well documented for several viruses including YFV. In the present study, the vector competence of Ae. aegypti mosquitoes collected from Gwalior, India for YFV 17D vaccine strain was evaluated to understand the risk of its transmission. Further the risk associated with transmission of YFV 17D vaccine strain from viremic vaccinees to mosquitoes and subsequently to naive individuals was assessed. Ae. aegypti were orally infected with high titer of YFV 17D strain and the infection status was investigated at 7 and 14 day post infection (dpi) using a highly sensitive quantitative RT-PCR assay. None of the Ae. aegypti mosquito orally infected with YFV 17D strain was found to be positive for YFV. The infection rate was found to be zero per cent at both 7 dpi and 14 dpi. These results demonstrated the inability of the YFV 17D strain to cause infection or replication in the midgut of Ae. aegypti. Due to the highly attenuated replication of this strain in Ae. aegypti midgut, there is a minimal risk of its transmission. Further, it is unlikely for a mosquito that feeds on a viremic vaccine to get infected with this vaccine strain. The risk of transmission of YFV 17D strain by Indian Ae. aegypti mosquitoes is negligible. Further vector competence study using epidemic strain of YFV will aid in risk assessment analysis of YFV in India. view of this, Indian Ae. aegypti were orally infected with YF 17D vaccine virus and their potential to allow replication and transmission of YFV was assessed.
MAterIAlS And MethodS

Adaptation and Propagation of YFV 17d
Vaccine The virus was allowed to be adsorbed for 2 hrs at 37 °C with intermittent shaking in an incubator without CO 2 . Following adsorption, cells were washed with PBS. Fresh EMEM medium containing 2 per cent FBS was added and cells were incubated at 32 °C for 5 days up to the appearance of CPE. Cell control was kept alongside. After visualisation of CPE, cells were freeze-thawed and supernatant was harvested, filtered, aliquoted and stored at -80 °C for further use. The process was repeated twice and the virus at passage level 3 (P3) was used for further study.
titration of YFV
Virus was harvested on 5 dpi and titrated through plaque assay in Vero cells (African green monkey kidney cells). For this, Vero cells were seeded in 24 well plate (Greiner Bioone, Germany). After 24 hrs, medium was gently aspirated and cells were washed with PBS. Serial 10-fold dilutions of virus were prepared in EMEM and then Vero cells were infected with particular virus dilution in triplicate. After 2 hrs of virus adsorption, the medium was aspirated and replaced with overlay medium containing EMEM, 1.25 per cent methylcellulose, 2 per cent FBS and incubated for 5 days. The medium was removed and cells were fixed with chilled methanol. Subsequently, 0.25 per cent crystal violet was added to stain the cell monolayer. Plate was rinsed and dried at room temperature, and plaques were counted. Number of plaque per well was calculated and virus titer in terms of plaque-forming units (PFU/ml) was determined.
Mosquitoes
Ae. aegypti used in this study were collected from Gwalior district in 2010 and maintained as a colony in Vector Management Division, DRDE. The mosquitoes were kept at a temperature of 28 ± 2 °C with 70-80 per cent relative humidity and 14:10 light:dark photo period. As energy source, 10 per cent sucrose solution (soaked in cotton pads) was provided to adult mosquitoes and larvae were allowed to feed on yeast tablets.
oral Infection of YFV 17d Vaccine Strain in
Ae. Aegypti Mosquitoes Female Ae. aegypti (4-5 days old) were used for oral infection experiments. Prior to infectious blood meal, mosquitoes were starved for 24 hours, to enhance blood feeding. The infectious blood meal was prepared by adding 1 ml of YFV 17D vaccine in 2 ml of washed rabbit RBC's. ATP was added in the blood meal to a final concentration of 5 mM. Mosquitoes were orally infected through Hemotek feeding membrane using circulating water (maintained at 37 °C) as described previously 10 ( Fig. 1 ). After 45 min of feeding, two mosquitoes were collected for titration of imbibed virus. Sixteen Ae. aegypti from two independent experiments were processed on 7 and 14 dpi to determine infection rates as described previously 10 . 
Processing of Individual Mosquito and Viral
rnA extraction Individual Ae. aegypti mosquito was homogenised in 2 ml tubes by adding 300 µl of EMEM (Sigma, USA) and 2 mm stainless steel beads using a Tissue Lyser LT (Qiagen, Germany). The mosquito homogenate was then clarified by centrifugation at 6000 x g for 10 min. 140 µl of supernatant was used for extraction of RNA using QIAamp viral RNA mini kit (Qiagen, Germany). The RNA was finally eluted in 50 µl elution buffer. RNA from mosquito samples was subjected to YFV specific quantitative RT-PCR.
Oral infection and mosquito processing experiments were performed in BSL-3 laboratory.
Quantitative rt-Pcr
The primers for quantitative RT-PCR (qRT-PCR) assay were selected from a previously published report that targets the junction region of 5′ NTR and capsid gene melting curve analysis software of Mx3005P according to the manufacturer's instructions. The RNA copies from Ct values were extrapolated using a standard curve reported by Dash 12 , et al.
Statistics
Sixteen mosquitoes from two independent experiments were processed on 7 dpi and 14 dpi to determine infection rates. Data is represented as Mean ± Standard deviation (Microsoft Excel 2010).
reSultS
Propagation and titration of YFV
After serial passage of YF 17D vaccine in C6/36 cells, YFV was produced. On 5 dpi, minor cytopathic effects like granulation, cell clumping were observed. Viral titer was found to be 5 × 10 4 PFU/ml, 8 × 10 5 PFU/ml, and 4 × 10 6 PFU/ml at P1, P2, and P3 respectively as calculated through plaque assay. Cytopathic effect and virus titration of P3 are shown in Fig. 2 (a) and 2(b), respectively. The virus at P3 was used for mosquito oral infection. 
Infection rates in Ae. aegypti
For oral infection experiment, 100 mosquitoes were used, out of which 65 mosquitoes were engorged with blood meal. From these 65 mosquitoes, 32 mosquitoes (stage 3+) 13 were selected for infectivity analysis at 7 dpi and 14 dpi. Viral RNA titer in blood meal was found to be 4 × 10 6 RNA copies/ml. Viral RNA titer in '0' day mosquito was found to be 4 × 10 4 RNA copies/ ml in 7 days and 14 days post infected mosquitoes. The infection rate of YFV in these mosquitoes was monitored at 7 dpi and 14 dpi, in which viral RNA copies were not detected in any of the Ae. aegypti mosquito, orally infected with YFV vaccine strain, as determined through quantitative RT-PCR assay. Thus the infection rate was found to be 0 per cent at both 7 dpi and 14 dpi (Fig. 3) .
dIScuSSIon
Yellow fever virus is the causal agent of yellow fever disease. It is endemic to tropical regions of Africa and central South America, affecting humans and non-human primates. The expansion in the geographical habitats of Ae. aegypti, the major vector of YFV, has led to severe epidemics of fatal hemorrhagic disease. Since 1950s, large outbreaks of YFV occurred in South America involving Peru, Bolivia, Brazil, Colombia, Ecuador. Despite mass vaccination campaigns to prevent these outbreaks, major YFV epidemics continued to occur 14 . Resurgence of YFV in South America has been attributed to low or incomplete vaccine coverage in endemic areas, urbanisation and human migration to forests 15 . Absence of YFV in Asia is an enigma to scientific fraternity. Several hypothesis including cross-immunity generated in response to other flaviviruses (Dengue and Japanese encephalitis virus) or due to low vector competence of Asian Ae. aegypti mosquitoes for YFV have been advocated. However, none of these have been proven scientifically. Increase in international travel and globalisation enhances the risk of YFV spread to South and South-East Asian countries with tropical climate. Rapid spread of the virus to areas with high vector density and naive population like India and other South-East Asian countries could potentially occur 16 . The recent introduction and successful establishment of West Nile virus, Chikungunya virus and Zika virus in naive territories reflects the real threat of arboviral infections.
Several studies have been performed to analyse the risk associated with the transmission of the vaccine strains from viremic vaccinees to mosquitoes and then from mosquitoes to naive individuals. Only 10 per cent oral infection rates were observed in Ae. aegypti from Peurto Rico, while 100 per cent infection rates were obtained upon intra-thoracic (IT) inoculation 17 . However, IT route does not demonstrate natural infection process as the midgut barriers are bypassed, so this does not reflect the actual scenario.
Besides this, the assessment of vector competence from different geographical strains of mosquitoes for different viral strains is important to estimate the risks associated with potential outbreaks. Vector competence is the susceptibility of a (b) (a) vector to oral infection and transmission of a pathogen. Several previous reports have demonstrated the vector competence of Ae. aegypti from different geographical locations for YFV. Australian population of Ae. aegypti was found to be susceptible for African strain of YFV as >70 per cent infectivity and >50 per cent transmission was achieved. However, the infection and transmission rates were lower for South American strains of YFV 18 . Also, Ae. aegypti population from Santa Cruz and Bolivia showed infectivity and transmissibility for South American YFV strain 19 . Other vectors like Ae. simpsoni, Ae. furcifer are also susceptible to the African YFV suggesting the sylvatic mode of transmission between monkeys 20 . Other mechanisms of arboviral transmission in nature is vertical transmission i.e. the transmission of virus from infected female mosquito to progenies. This is considered as an alternative survival mechanism for virus in nature. Vertical transmission of YFV by Ae. aegypti was demonstrated naturally from field collected male and female mosquitoes 21 . Experimental evidence was provided with Ae. aegypti colonies from Dakar and Koungheul that transmitted YFV to male and female progenies with increase in infection rates at later oviposition cycles 22 .
In the present study, we evaluated the vector competence of YFV 17D vaccine strain for Indian Ae. aegypti mosquitoes. Vector competence is greatly affected by oral infectious dose (OID) provided to mosquitoes. It has been observed that, upon increasing viral dose, infectivity increased in mosquitoes 23 . Therefore a high dose is provided in these experiments to maximise the chances of infection. Detection and quantification of YFV in YFV 17D vaccine virus was performed using a highly sensitive quantitative RT-PCR assay. The YFV in infected mosquitoes was titrated as RNA copies rather than the infectious virus because of the high sensitivity of real time RT-PCR compared to the conventional plaque assay. The sensitivity of YFV specific quantitative RT-PCR assay employed in this study was found to be high as it has a detection limit of 30 RNA copies/reaction 12 . The infection rate of YFV in Ae. aegypti mosquitoes was monitored at 7 and 14 dpi. It was observed that none of the Ae. aegypti mosquito orally infected with YFV 17D strain was found to be positive for YFV. The infection rate was found to be 0 per cent at both 7 and 14 dpi. Our results are in agreement with a previous report, where infection rate was found to be 0 per cent in orally infected Ae. aegypti from Thailand 24 . These results demonstrated the inability of the YFV 17D strain to cause infection or replication in the midgut epithelial cells of Indian Ae. aegypti, representing the negligible risk of YFV spread in India. The inability of 17D strain to establish infection in midgut led to failure in dissemination and further transmission of the YFV. Several factors including genetics of both virus and vector along with midgut microflora might have attributed to this refractoriness 25 He has published more than 40 articles in international journals. His research focussses on development of newer insect repellents and molecules for control/management of arthropod vectors, Surveillance and preparation of a databank on arthropod vectors of defence importance along the northern western border of India. He has made significant contributions in development of improved lethal ovi-larvicidal ovitraps for mosquitoes, personal protective measures for Indian Armed forces using repellent textiles and traps. In the current study, he performed vector experiments, analysed the data.
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